Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision updated from v3.6.5 to v3.6.6, indicating a new version of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, signaling a platform update. It does not alter the study details or content presented on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a metadata or backend update to the page version.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision tag on the page updated from v3.6.2 to v3.6.3, signaling a minor maintenance release. This update does not modify the study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.6.2 and removed Revision: v3.6.0 to update the page's revision history.SummaryDifference0.1%

- Check91 days agoChange DetectedEnrollment status now indicates that the study is not recruiting participants, signaling that enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and there are minor formatting/version updates (Intervention/Treatment formatting and Revision: v3.6.0).SummaryDifference0.5%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.